Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,416.83
(
0.21%
)
US TECH 100
28,413.60
(
0.44%
)
Dow Jones
49,504.51
(
-0.51%
)
Brent Oil
104.45
(
-1.24%
)
Bitcoin
78,833.71
(
-2.06%
)
News Focus
News Focus
Post# of 6105
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122973
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: corporalagarn post# 5734

Tuesday, 11/18/2025 1:53:24 PM

Tuesday, November 18, 2025 1:53:24 PM

Post# of 6105
A third possibility, albeit less likely, is that ENTA sells the RSV program for cash and continues as a pure-play immunology company. BHVN did something similar to this when PFE acquired its migraine program.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent ENTA News
More ENTA News